Skip to main navigation Skip to search Skip to main content

A Phase 2a, Randomized, Placebo-Controlled, Double-Blind Multiple Ascending Dose Study in Patients with Cystic Fibrosis Carrying the 3849 +10 Kb C->T Mutation to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84

Project: Research project

Project Details

StatusActive
Effective start/end date7/1/26 → 6/30/36

Funding

  • SPLISENSE, LTD